Search results
Results from the WOW.Com Content Network
This antigen presentation pathway enables the immune system to detect transformed or infected cells displaying peptides from modified-self (mutated) or foreign proteins. [ 5 ] [ 6 ] In the presentation process, these proteins are mainly degraded into small peptides by cytosolic proteases in the proteasome , but there are also other cytoplasmic ...
This process involves two distinct pathways for processing of antigens from an organism's own (self) proteins or intracellular pathogens (e.g. viruses), or from phagocytosed pathogens (e.g. bacteria); subsequent presentation of these antigens on class I or class II major histocompatibility complex (MHC) molecules is dependent on which pathway ...
As a consequence, external soluble antigens are targeted into the MHC class I cross-presentation pathway instead of the MHC Class II pathway. [citation needed] However, there is still uncertainty in regard to a mechanistic pathway for cross presentation within an antigen presenting cell. Currently, there are two main pathways proposed ...
This pMHC is capable of normal antigen presentation to effectors cells. Usually, the mechanism of cross-dressing serves purposes of amplifying immune response to certain antigens , but in case of alloantigen recognition the APCs are able, thanks to this mechanism, to prime both direct and indirect T lymphocytes by expressing both self- MHC and ...
It is in this way, the MHC class I-dependent pathway of antigen presentation, that the virus infected cells signal T-cells that abnormal proteins are being produced as a result of infection. The fate of the virus-infected cell is almost always induction of apoptosis through cell-mediated immunity, reducing the risk of infecting neighboring ...
Antigen presentation stimulates immature T cells to become either mature "cytotoxic" CD8+ cells or mature "helper" CD4+ cells. An antigen-presenting cell (APC) or accessory cell is a cell that displays an antigen bound by major histocompatibility complex (MHC) proteins on its surface; this process is known as antigen presentation.
These cell death pathways help clear infected or aberrant cells and release cellular contents and inflammatory mediators. Chemical factors produced during inflammation ( histamine , bradykinin , serotonin , leukotrienes , and prostaglandins ) sensitize pain receptors , cause local vasodilation of the blood vessels , and attract phagocytes ...
Artificial antigen presenting cells (aAPCs) are engineered platforms for T-cell activation. aAPCs are used as a new technology and approach to cancer immunotherapy. Immunotherapy aims to utilize the body's own defense mechanism—the immune system —to recognize mutated cancer cells and to kill them the way the immune system would recognize ...